217 related articles for article (PubMed ID: 27498826)
21. Phenotypic and Genotypic Comparison of a Live-Attenuated Genotype I Japanese Encephalitis Virus SD12-F120 Strain with Its Virulent Parental SD12 Strain.
Anwar MN; Wang X; Hameed M; Wahaab A; Li C; Sharma M; Pang L; Malik MI; Liu K; Li B; Qiu Y; Wei J; Ma Z
Viruses; 2020 May; 12(5):. PubMed ID: 32429445
[TBL] [Abstract][Full Text] [Related]
22. Differences in haemagglutination activity and electrophoretic mobility of E protein between the parent SA14 and attenuated vaccine SA14-14-2 strains of Japanese encephalitis virus.
Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
Acta Virol; 1995 Apr; 39(2):109-11. PubMed ID: 7676935
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14.
Ni H; Chang GJ; Xie H; Trent DW; Barrett AD
J Gen Virol; 1995 Feb; 76 ( Pt 2)():409-13. PubMed ID: 7844560
[TBL] [Abstract][Full Text] [Related]
24. Immune response in mice infected with the attenuated Japanese encephalitis vaccine strain SA14-14-2.
Lee T; Komiya T; Watanabe K; Aizawa C; Hashimoto H
Acta Virol; 1995 Jun; 39(3):161-4. PubMed ID: 8578998
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo characterization of chimeric duck Tembusu virus based on Japanese encephalitis live vaccine strain SA14-14-2.
Wang HJ; Liu L; Li XF; Ye Q; Deng YQ; Qin ED; Qin CF
J Gen Virol; 2016 Jul; 97(7):1551-1556. PubMed ID: 27100268
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
Janewongwirot P; Puthanakit T; Anugulruengkitt S; Jantarabenjakul W; Phasomsap C; Chumket S; Yoksan S; Pancharoen C
Vaccine; 2016 Oct; 34(44):5279-5283. PubMed ID: 27628323
[TBL] [Abstract][Full Text] [Related]
27. [Progress in the research of phenotype and genotype of Japanese encephalitis virus in China].
Chen N; Yu YX
Bing Du Xue Bao; 2013 Jun; 29(4):457-64. PubMed ID: 23895014
[TBL] [Abstract][Full Text] [Related]
28. Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.
Li Z; Yang H; Yang J; Lin H; Wang W; Liu L; Zhao Y; Liu L; Zeng X; Yu Y; Li Y
Virus Res; 2014 Oct; 191():10-20. PubMed ID: 25091563
[TBL] [Abstract][Full Text] [Related]
29. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2.
Li XF; Zhao W; Lin F; Ye Q; Wang HJ; Yang D; Li SH; Zhao H; Xu YP; Ma J; Deng YQ; Zhang Y; Qin ED; Qin CF
J Gen Virol; 2013 Dec; 94(Pt 12):2700-2709. PubMed ID: 24092759
[TBL] [Abstract][Full Text] [Related]
30. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.
Van Gessel Y; Klade CS; Putnak R; Formica A; Krasaesub S; Spruth M; Cena B; Tungtaeng A; Gettayacamin M; Dewasthaly S
Vaccine; 2011 Aug; 29(35):5925-31. PubMed ID: 21723353
[TBL] [Abstract][Full Text] [Related]
31. The pre membrane and envelope protein is the crucial virulence determinant of Japanese encephalitis virus.
Leng SL; Huang R; Feng YN; Peng LJ; Yang J; Li YH
Microb Pathog; 2020 Nov; 148():104492. PubMed ID: 32916243
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
33. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
[TBL] [Abstract][Full Text] [Related]
34. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
[TBL] [Abstract][Full Text] [Related]
35. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines.
Monath TP; Arroyo J; Levenbook I; Zhang ZX; Catalan J; Draper K; Guirakhoo F
J Virol; 2002 Feb; 76(4):1932-43. PubMed ID: 11799188
[TBL] [Abstract][Full Text] [Related]
36. Low Protective Efficacy of the Current Japanese Encephalitis Vaccine against the Emerging Genotype 5 Japanese Encephalitis Virus.
Cao L; Fu S; Gao X; Li M; Cui S; Li X; Cao Y; Lei W; Lu Z; He Y; Wang H; Yan J; Gao GF; Liang G
PLoS Negl Trop Dis; 2016 May; 10(5):e0004686. PubMed ID: 27139722
[TBL] [Abstract][Full Text] [Related]
37. Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain.
Zheng X; Yu X; Wang Y; Cui M; Wang R; Yin C
Infect Genet Evol; 2020 Nov; 85():104443. PubMed ID: 32619637
[TBL] [Abstract][Full Text] [Related]
38. A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS; Houillon G; Jang GC; Cha SH; Choi SH; Lee J; Kim HM; Kim JH; Kang JH; Kim JH; Kim KH; Kim HS; Bang J; Naimi Z; Bosch-Castells V; Boaz M; Bouckenooghe A
Hum Vaccin Immunother; 2014; 10(9):2656-63. PubMed ID: 25483480
[TBL] [Abstract][Full Text] [Related]
39. [Studies on the biological and genetic characteristics of a highly neurovirulent Japanese encephalitis virus strain SA4].
Liu XY; Yu YX; Yue GZ; Yang LH; Jia LL; Dong GM
Bing Du Xue Bao; 2010 Jul; 26(4):265-70. PubMed ID: 20836378
[TBL] [Abstract][Full Text] [Related]
40. Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives.
Ni H; Burns NJ; Chang GJ; Zhang MJ; Wills MR; Trent DW; Sanders PG; Barrett AD
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1505-10. PubMed ID: 8207417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
